ThinkPanmure Initiates Coverage on Human Genome Sciences (HGSI) with a Sell
ThinkPanmure initiates coverage on Human Genome Sciences (HGSI) with a Sell. Price target $1.50.
Human Genome Sciences (HGS) is a commercially focused biopharmaceutical company.
Stocks Mentioned
Related Entities
Comments
HGSI
i will book that bet. also i will give you 10-1 odds that HGSI hits $% before it hits a buck and and a half. you guys are morons!!!
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
HGSI
palaceplace on Feb 19, 2009 06:16 PMoops! the $% should be $5